Active Ingredient: APREMILAST
Proprietary Name: APREMILAST
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A211897
Product Number: 001
Approval Date: Aug 18, 2022
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Discontinued
Patent and Exclusivity Information